Clinical Trial Update: Camrelizumab Combined With Intraperitoneal Infusion of Nab-paclitaxel, Intravenous Chemotherapy and S-1 in the Treatment of Advanced Gastric Cancer With Peritoneal Metastasis：Single-arm, Prospective Clinical Study [Phase 2]

View source ↗

Summary

A single-arm Phase 2 clinical trial evaluating camrelizumab with intraperitoneal nab-paclitaxel, intravenous chemotherapy, and S-1 for advanced gastric cancer w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Peritoneal Metastasis

Drugs mentioned

• Camrelizumab (camrelizumab)
• Nab-paclitaxel (paclitaxel protein-bound)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Zhongshan Hospital Xiamen University | Conditions: Stage IV Gastric Cancer With Metastasis | Phase 2 | Status: UNKNOWN